Share on StockTwits

AstraZeneca plc (LON: AZN) was the recipient of a ratings changes during the seven days:

  • AstraZeneca plc was downgraded by analysts at Societe Generale to a “sell” rating. They now have a GBX 3,600 ($60.35) price target on the stock.
  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Jefferies Group. They now have a GBX 5,000 ($83.82) price target on the stock.
  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Beaufort Securities.
  • AstraZeneca plc had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a GBX 4,900 ($82.15) price target on the stock.
  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Deutsche Bank. They now have a GBX 3,950 ($66.22) price target on the stock.
  • AstraZeneca plc had its “neutral” rating reaffirmed by analysts at Credit Suisse. They now have a GBX 4,800 ($80.47) price target on the stock.

Shares of AstraZeneca plc (LON:AZN) opened at 4369.50 on Wednesday. AstraZeneca plc has a 1-year low of GBX 3028.50 and a 1-year high of GBX 5750.00. The stock’s 50-day moving average is GBX 4352.33 and its 200-day moving average is GBX 3921.. The company’s market cap is £55.099 billion.

AstraZeneca PLC (LON:AZN) is a global biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.